WASHINGTON, D.C.— Rep. Leonard Lance (R-NJ-07), Rep. Anna G. Eshoo (D-CA-14) and 112 Members of Congress are calling for action on H.R. 733, the ‘Pancreatic Cancer Research and Education Act.’ The lawmakers are urging the House Energy and Commerce Committee, of which Lance is a member, to mark-up the bipartisan legislation so that it can move forward.
Eshoo reintroduced the ‘Pancreatic Cancer Research and Education Act’ earlier during this session of Congress. The bill has 273 bipartisan House cosponsors, including New Jersey representatives Lance, Rush Holt (D-NJ-12), Frank Pallone (D-NJ-6), Bill Pascrell (D-NJ-8), Steve Rothman (D-NJ-9), Albio Sires (D-NJ-13), Frank LoBiondo (R-NJ-2), Jon Runyan (R-NJ-3), Chris Smith (R-NJ-4), Rodney Frelinghuysen (R-NJ-11), and Rob Andrews (D-NJ-1).
The legislation establishes a national Pancreatic Cancer Initiative, creating a strategic plan to target the high mortality rate associated with the disease and to give the National Cancer Institute the tools it needs for earlier diagnosis, better treatment, and hope for a cure.
“Pancreatic cancer is the fourth leading cause of cancer death. It is a disease without a cure or any means of early detection,” Lance said. “Yet despite these sobering statistics, America lacks a comprehensive, strategic plan to fight pancreatic cancer. To this end, I stand firm with pancreatic cancer patients and their families and my colleagues in the House and Senate in hope that a better plan is put forward so that a cure can be found to this terrible disease.”